Citation: Gl. Kaluza et al., Intracoronary radiotherapy for prevention of restenosis after percutaneouscoronary interventions, ANN MED, 32(9), 2000, pp. 622-631
Citation: Jx. Rong et Ea. Fisher, High-density lipoprotein: gene-based approaches to the prevention of atherosclerosis, ANN MED, 32(9), 2000, pp. 642-651
Authors:
Rautelin, HIK
Oksanen, AM
Karttunen, RA
Seppala, KMY
Virtamo, JRK
Aromaa, AJ
Kosunen, TU
Citation: Hik. Rautelin et al., Association of CagA-positive infection with Helicobacter pylori antibodiesof IgA class, ANN MED, 32(9), 2000, pp. 652-656
Citation: S. Fichtlscherer et Am. Zeiher, Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels, ANN MED, 32(8), 2000, pp. 515-518
Citation: K. Yamada et al., Bombesin-like peptides: studies on food intake and social behaviour with receptor knock-out mice, ANN MED, 32(8), 2000, pp. 519-529
Authors:
Imagawa, A
Hanafusa, T
Miyagawa, J
Matsuzawa, Y
Citation: A. Imagawa et al., A proposal of three distinct subtypes of type 1 diabetes mellitus based onclinical and pathological evidence, ANN MED, 32(8), 2000, pp. 539-543
Citation: G. Monteleone et Tt. Macdonald, Manipulation of cytokines in the management of patients with inflammatory bowel disease, ANN MED, 32(8), 2000, pp. 552-560
Citation: E. Van De Graaff et Sr. Steinhubl, Antiplatelet medications and their indications in preventing and treating coronary thrombosis, ANN MED, 32(8), 2000, pp. 561-571
Citation: Te. Strandberg et al., Associations between change in C-reactive protein and serum lipids during statin treatment, ANN MED, 32(8), 2000, pp. 579-583
Citation: H. Rautelin et Ml. Hanninen, Campylobacters: the most common bacterial enteropathogens in the Nordic countries, ANN MED, 32(7), 2000, pp. 440-445
Citation: Jc. Ter Maaten, Should we start and continue growth hormone (GH) replacement therapy in adults with GH deficiency?, ANN MED, 32(7), 2000, pp. 452-461